1. Sassi A, Loucif L, Gupta SK, Dekhil M, Chettibi H, Rolain JM. NDM-5 carbapenemase encoding gene in multidrug-resistant clinical isolates of
Escherichia coli from Algeria. Antimicrob Agents Chemother. 2014; 58:5606–5608. PMID:
24982080.
2. Ahn S, Sung JY, Kim H, Kim MS, Hwang Y, Jong S, et al. Molecular epidemiology and characterization of carbapenemase-producing Enterobacteriaceae isolated at a university hospital in Korea during 4-year period. Ann Clin Microbiol. 2016; 19:39–47.
3. Jeong SH, Kim HS, Kim JS, Shin DH, Kim HS, Park MJ, et al. Prevalence and molecular characteristics of carbapenemase-producing
Enterobacteriaceae from five hospitals in Korea. Ann Lab Med. 2016; 36:529–535. PMID:
27578505.
4. Dortet L, Poirel L, Al Yaqoubi F, Nordmann P. NDM-1, OXA-48 and OXA-181 carbapenemase-producing
Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect. 2012; 18:E144–E148. PMID:
22404169.
5. Yoo JS, Kim HM, Koo HS, Yang JW, Yoo JI, Kim HS, et al. Nosocomial transmission of NDM-1-producing
Escherichia coli ST101 in a Korean hospital. J Antimicrob Chemother. 2013; 68:2170–2172. PMID:
23696618.
6. Park M, Park SD, Lee MH, Kim SH, Lim K, Lee G, et al. The first report of NDM-5-producing uropathogenic
Escherichia coli isolates in South Korea. Diagn Microbiol Infect Dis. 2016; 85:198–199. PMID:
27049587.
7. Khajuria A, Praharaj AK, Kumar M, Grover N. Emergence of Escherichia coli, co-producing NDM-1 and OXA-48 carbapenemases, in urinary isolates, at a tertiary care centre at Central India. J Clin Diagn Res. 2014; 8:DC01–DC04.
8. Song W, Yoo G, Hwang GY, Uh Y. Evaluation of diagnostic performance of RAPIDEC CARBA NP test for carbapenemase-producing Enterobacteriaceae. Ann Clin Microbiol. 2016; 19:59–64.
9. Wang HY, Yoo G, Kim J, Uh Y, Song W, Kim JB, et al. Development of a rapid reverse blot hybridization assay for detection of clinically relevant antibiotic resistance genes in blood cultures testing positive for gramnegative bacteria. Front Microbiol. 2017; 8:185. PMID:
28232823.
10. CLSI. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100-S27. 27th ed. Wayne, PA: Clinical and Laboratory Standards Institute;2017.